Kentucky Governor Expands Medical Cannabis Eligibility Via Order

Executive Order Adds Conditions Beyond Legislative Framework

The June 3 order adds chronic pain, PTSD, anxiety disorders, and treatment-resistant depression to Kentucky's medical cannabis qualifying-condition list. These conditions supplement the 21 diagnoses enumerated in House Bill 136, the 2023 statute that legalized medical cannabis in Kentucky. The expansion doesn't require legislative approval under the executive-branch rulemaking authority granted by HB 136.

The Kentucky Cabinet for Health and Family Services will incorporate the new conditions into administrative regulations currently under development. Public comment on those regulations closed May 15. Final rules are expected by September 2026.

Chronic Pain Provision Mirrors Neighboring States

Kentucky's chronic pain qualifier aligns the state with Ohio, West Virginia, and Illinois, all of which permit cannabis for intractable pain unresponsive to conventional treatment. The order defines chronic pain as persistent pain lasting at least three months and documented by a physician. It doesn't specify a minimum severity threshold or require prior opioid therapy, distinguishing Kentucky's framework from Ohio's more restrictive standard.

Industry observers note the chronic pain addition could significantly expand patient eligibility. A 2024 University of Louisville study estimated that 18% of Kentucky adults—roughly 600,000 residents—report chronic pain conditions. By contrast, the statutory list in HB 136, which includes cancer, epilepsy, and multiple sclerosis, covered an estimated 120,000 Kentuckians.

Mental Health Diagnoses Face Federal Scheduling Conflict

Adding PTSD, anxiety, and depression creates a potential federal-state conflict if cannabis remains a Schedule I controlled substance under the Controlled Substances Act. Federal law prohibits Schedule I drugs from having accepted medical use. Veterans Affairs physicians can't recommend cannabis for PTSD even in states where it's legal. Kentucky's order doesn't address how state-licensed physicians treating veterans or federal employees will navigate that conflict.

The mental health provisions put Kentucky ahead of most Southern states but behind the regulatory curve set by mature programs in Colorado and California, where PTSD has been a qualifier since 2010.

The Kentucky Medical Association hasn't issued a formal position on the executive order. A May 2026 survey of the association's members found that 62% supported medical cannabis legalization, but only 38% said they'd be willing to certify patients.

Program Launch Timeline Remains January 2027

The executive order doesn't alter the January 1, 2027, target date for patient registry enrollment or the March 2027 timeline for the first licensed dispensaries to open. The Kentucky Department of Agriculture is still processing cultivation license applications, with 47 grower permits issued as of May 30. No processor or dispensary licenses have been awarded. Those application windows open in August and October 2026, respectively.

For full background on Kentucky's regulatory buildout, see the CannIntel topic hub on Kentucky Medical Cannabis Program.

The next procedural milestone is the Cabinet for Health and Family Services' final rule publication, expected by September 15. That will lock in physician certification requirements, patient possession limits, and product testing standards. Stakeholders will be watching whether the final rules impose stricter controls on the newly added conditions or treat them identically to the statutory list.